KFDA to put human placenta drugs under DMF control.

Published: 2006-01-04 06:57:00

Updated: 2006-01-04 06:57:00

A human placenta preparation, a popular drug for the treatment of climacteric symptoms, seems to be listed under the DMF (Data master file) control to reinforce its quality controls.

The KFDA announced to disclose "Revised bill for the guideline of bulk drug report" in advance, covering that ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK